Barrier effect of Esoxx® on esophageal mucosal damage: Experimental study on ex-vivo swine model

Clinical and Experimental Gastroenterology

Volumn 5, Issue 1, 2012, Pages 103-107

  Di Simone, Massimo P ^a   Baldi, Fabio ^a   Vasina, Valentina ^a   Scorrano, Fabrizio ^a   Bacci, Maria Laura ^a   Ferrieri, Antonella ^b   Poggioli, Gilberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Alfa Wassermann SpA   (Italy)

Author keywords

Animal model; Bioadhesion; Esophagus; Evans blue dye; Hyaluronic acid; Reflux esophagitis

Indexed keywords

ESOXX; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; EX VIVO STUDY; EXPERIMENTAL STUDY; HISTOPATHOLOGY; MEMBRANE PERMEABILITY; NONHUMAN; SWINE;

EID: 84864039332     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S31404     Document Type: Article

References (25)

1. Batchelor HK. Novel bioadhesive formulations in drug delivery. Drug Delivery Companies Report Autumn/Winter. 2004:16-19.
2. Volpi N, Schiller J, Stern R, Soltés L. Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem. 2009;16(14):1718-1745.
3. Nolan A, Baillie C, Badminton J, Rudralingham M, Seymour RA. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. J Oral Pathol Med. 2006;35(8):461-465.
4. Kapoor P, Sachdeva S, Sachdeva S. Topical hyaluronic Acid in the management of oral ulcers. Indian J Dermatol. 2011;56(3):300-302.
5. Lauder RM. Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems. Complement Ther Med. 2009;17(1):56-62.
6. Du Souich P, García AG, Vergés J, Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med. 2009; 13(8A):1451-1463.
7. Palmieri B, Corbascio D, Capone S, Lodi D. Preliminary clinical experience with a new natural compound in the treatment of oesophagitis and gastritis: symptomatic effect. Trends Med. 2009;9(4):219-225.
8. Richardson JC, Dettmar PW, Hampson FC, Melia CD. Esophageal bioadhesion of sodium alginate suspensions. Suspension behaviour on esophageal mucosa. Eur J Pharm Sci. 2005;24:107-114.
9. Pursnani KG, Mohiuddin MA, Geisinger KR, Weinbaum G, Katzka DA, Castell DO. Experimental study of acid burden and acute oesophagitis. Br J Surg. 1998;85(5):677-680.
10. Lanas A, Royo Y, Ortego J, Molina M, Sáinz R. Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis. Gastroenterology. 1999;116(1):97-107.
11. Kaya M, Ahishali B. Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase. Methods Mol Biol. 2011;763:369-382.
12. Lange S, Delbro DS, Jennische E. Evans blue permeation of intestinal mucosa in the rat. Scand J Gastroenterol. 1994;29:38-46.
13. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM. In vitro model of acute esophagitis in the cat. Am J Physiol Gastrointest Liver Physiol. 2005;289:G860-G869.
14. Al-Dujaili H, Florence AT, Salole EG. The adhesiveness of proprietary tables and capsules to porcine oesophageal tissue. Int J Pharm. 1986;34:75-79.
15. Honkanen O, Pia L, Marvola J, Sari E, Raimo T, Marvola M. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations. Eur J Pharm Sci. 2002;15:479-488.
16. Batchelor HK, Banning D, Dettmar PW, Hampson FC, Jolliffe IG, Craig DQ. An in vitro mucosal model for prediction of the bioadhesion of alginate solutions to the oesophagus. Int J Pharm. 2002;238:123-132.
17. Marvola M, Vahervuo K, Sothmann A, Marttila E, Rajaniemi M. Development of a method for study the tendency of drug products to adhere to the esophagus. J Pharm Sci. 1982;71:975-977.
18. Orlando RC. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract Res Clin Gastroenterol. 2010;24:873-882.
19. Saria A, Lundberg JM. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods. 1983;8(1):41-49.
20. Kitajima S, Takuma S, Morimoto M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim. 1999;48:137-143.
21. Gaffney J, Matou-Nasri S, Grau-Olivares M, Slevin M. Therapeutic applications of hyaluronan. Mol Biosyst. 2010;6(3):437-443.
22. Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater. 2011;23(12):H41-H56.
23. Ardizzoni A, Neglia RG, Baschieri MC, et al. Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens. J Mater Sci Mater Med. 2011;22(10):2329-2338.
24. Kogan G, Soltés L, Stern R, Gemeiner P. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett. 2007;29(1):17-25.
25. Dobrozsi DJ, Smith RL, Sakr AA. Comparative mucoretention of sucralfate suspensions in an everted rat esophagus model. Int J Pharm. 1999;189:81-89.